In the second segment of this three-part review of parasitic infections of the central nervous system in children, we consider parasitic infections which typically involve various tissues and organs in addition to the brain and spinal cord. Parasites capable of dissemination in immunocompetent hosts are discussed first, and, as in Part I, organisms are grouped according to their predominant geographic location. This is followed by a discussion of the unique aspects of toxoplasmosis, strongyloidiasis and infection with microsporidia in immunocompromised patients, with an emphasis on the central nervous system. (J Child Neurol 1995;10:77-87).
Get full access to this article
View all access options for this article.
References
1.
World Health Organization Malaria Action Programme : Severe and complicated malaria. Trans R Soc Trop Med Hyg1990; 84(Suppl 2):1-65.
2.
Warrell DA: Cerebral malaria. Q J Med (New Series 71) 1989; 265:369-371.
3.
Molyneux ME, Taylor TE, Wirima JJ, Borgstein A.: Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children. Q J Med1989;71: 441-459.
4.
Aikawa M., Iseki M., Barnwell JW, et al: The pathology of human cerebral malaria. Am J Trop Med1990;43(Suppl):30-37.
5.
MacPherson GG , Warrell MJ, White NJ, et al: Human cerebral malaria: A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol1985;119:385-401.
6.
Sein KK, Maeno Y., Thuc HV, et al: Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg1993;48:504-511.
7.
Grau GE, Taylor TE, Molyneux ME, et al: Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med1989;320:1586-1591.
8.
Newton Crjc, Kirkham FJ, Winstanley PA, et al: Intracranial pressure in African children with cerebral malaria . Lancet1991;337:573-576.
9.
A. Newton Crjc , Peshu N., Kendall B., et al: Brain swelling and ischemia in Kenyans with cerebral malaria. Arch Dis Child1994 ;70:281-287.
10.
Chabasse D., Drouet F., Bidault P., et al: Forme neurologique ou accès pernicieux a Plasmodium malariae. Discussion physiopathologique a propos d'une observation. Bull Soc Pathol Exot1981;74:171-175.
Spielman A. , Perrone JB, Teklehaimanot A., et al: Malaria diagnosed by direct observation of centrifuged samples of blood. Am J Trop Med Hyg1988;39:337-342.
13.
Tirasophon W., Ponglikitmongkol M., Wilairat P., et al: A novel detection of a single Plasmodium falciparum in infected blood. Biochem Biophys Res Commun1991;175:179-184.
14.
Brewster DR , Kwiatkowski D., White NJ: Neurological sequelae of cerebral malaria in children. Lancet1990 ;336:1039-1043.
15.
Chia JKS , Nakata MM, Schenley C.: Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon, letter. J Infect Dis1992;165:599-600.
16.
A. Zucker JR, Campbell CC: Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum in the Amazon. J Infect Dis1992;166:1458-1459.
17.
Stace J., Bilton P., Coates K., Stace N.: Cerebral malaria in children: A retrospective study of admissions to Madang Hospital, 1980. P N G Med J1982 ;25:230-234.
18.
Wright PW, Avery WG, Ardill WD, McLarty JW: Initial clinical assessment of the comatose patient: Cerebral malaria vs meningitis . Pediatr Infect Dis J1993;12:37-41.
Molyneux ME : Cerebral malaria in children: Clinical implications of cytoadherence. Am J Trop Med Hyg1990;43(Suppl): 38-41.
21.
Phillips RE , Warrell DA, White NJ, et al: Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med1985;312:1273-1278.
22.
Miller KD, Greenberg AE, Campbell CC: Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med1989;321:65-70.
23.
Centers for Disease Control: Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: Discontinuation of parenteral quinine from CDC drug service. MMWR1991;40:21-23.
24.
Okitolonda W., Delacollette C., Malengreau M., Henquin JC: High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. BMJ1987;295:716-718.
25.
White NJ, Pukrittayakamee S.: Clinical malaria in the tropics. Med J Aust1993;159:197-203.
26.
Pasvol G., Newton Crjc, Winstanley PA, et al: Quinine treatment of severe falciparum malaria in African children: A randomized comparison of three regimens. Am J Trop Med Hyg1991;45:702-713.
27.
White NJ, Phillips RE, Looareesuwan S., et al: Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet1988;2:64-66.
28.
Warrell DA , Looareesuwan S., Warrell MJ, et al: Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med1982;306:313-319.
29.
Phillips P. , Nantel S., Benny WB: Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: Case report and review. Rev Infect Dis1990 ;12:1100-1108.
30.
Gendrel D. , Kombila M., Nardou M., et al: Protection against Plasmodium falciparum infection in children with hemoglobin S. Pediatr Infect Dis J1991 ;10:620-621.
31.
Smith MHD , Beaver PC: Persistence and distribution of Toxocara larvae in the tissues of children and mice. Pediatrics1953;12:491-497.
32.
Fortenberry JD, Kenney RD, Younger J.: Visceral larva migrans producing static encephalopathy in an infant. Pediatr Infect Dis J1991;10:403-406.
33.
Dent JH, Nichols RL, Beaver PC, et al: Visceral larva migrans with a case report. Am J Pathol1956;32:777-803.
34.
Beaver PC, Snyder CH, Carrera GM, et al: Chronic eosinophilia due to visceral larva migrans. Pediatrics1952;9:7-19.
35.
Snyder CH: Visceral larva migrans: Ten years' experience. Pediatrics1961;28:85-91.
36.
Beautyman W. , Beaver PC, Buckley JJC, Woolf AL: Review of a case previously reported as showing an ascarid larva in the brain. J Pathol Bacteriol1966;91:271-273.
37.
Moore MT: Human Toxocara canis encephalitis with lead encephalopathy. J Neuropathol Exp Neurol1962;21:201-218.
38.
Schochet SS : Human Toxocara canis encephalopathy in a case of visceral larva migrans. Neurology1967;17:227-229.
39.
Mikhael NZ, Montpetit VJA, Orizaga M., et al: Toxocara canis infestation with encephalitis. Can J Neurol Sci1974;1:114-120.
40.
Hill IR, Denham DA, Scholtz CL: Toxocara canis larvae in the brain of a British child. Trans R Soc Trop Med Hyg1985;79: 351-354.
41.
Anderson DC , Greenwood R., Fishman M., Kagan IG: Acute infantile hemiplegia with cerebrospinal fluid eosinophilic pleocytosis: An unusual case of visceral larva migrans . J Pediatr1975 ;86:247-249.
42.
Glickman LT , Cypress RH, Crumrine PK, Gitlin DA: Toxocara infection and epilepsy in children . J Pediatr1979;94:75-78.
43.
Worley G., Green JA, Frothingham TE, et al: Toxocara canis infection: Clinical and epidemiological associations with seropositivity in kindergarten children. J Infect Dis1984;149: 591-597.
44.
Marmor M., Glickman L., Shofer F., et al: Toxocara canis infection of children: Epidemiologic and neuropsychologic findings. Am J Public Health1987;77:554-559.
45.
Glickman LT , Schantz PM, Cypress RH: Epidemiological characteristics and clinical findings in patients with serologically proven toxocariasis. Trans R Soc Trop Med Hyg1979;73: 254-258.
46.
Nichols RL: The etiology of visceral larva migrans: Diagnostic morphology of infective second-stage Toxocara larvae. J Parasitol1956;42:349-362.
47.
Parsons JC, Bowman DD, Grieve RB: Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. Am J Trop Med Hyg1986;35: 974-981.
48.
Stürchler D. , Schubarth P., Gualzata M., et al: Thiabendazole vs albendazole in treatment of toxocariasis: A clinical trial. Ann Trop Med Parasitol1989;83:473-478.
49.
Drugs for parasitic infections. Med Lett Drugs Ther1993;35: 111-122.
50.
Dalessio DJ , Wolff HG: Trichinella spiralis infection of the central nervous system. Arch Neurol1961;4:67-77.
51.
Barr R.: Human trichinosis: Report of four cases, with emphasis on central nervous system involvement, and a survey of 500 consecutive autopsies at the Ottawa Civic Hospital. Can Med Assoc J1966 ;95:912-917.
52.
Ellrodt A., Halfon P., LeBras P., et al: Multifocal central nervous system lesions in three patients with trichinosis. Arch Neurol1987;44:432-434.
53.
Gray DF, Morse BS, Phillips WF: Trichinosis with neurologic and cardiac involvement. Review of the literature and report of three cases. Ann Intern Med1962;57:230-244.
54.
Ryczak M., Sorber WA, Kandora TF, et al: Difficulties in diagnosing Trichinella encephalitis. Am J Trop Med Hyg1987;36: 573-575.
55.
Most H.: Trichinosis—preventable yet still with us. N Engl J Med1978;298:1178-1180.
56.
Lyon-Caen O. , Hauw J-J., Vitoux J-F., et al: La trichinose du système nerveux central: Une observation. Nouv Presse Med1982;11:2343-2346.
Kreel L., Poon WS, Nainby-Luxmoore JC: Trichinosis diagnosed by computed tomography. Postgrad Med J1988;64:626-630.
59.
McCracken RO , Taylor DD: Mebendazole therapy of parenteral trichinellosis . Science1980;207:1220-1222.
60.
Levin ML: Treatment of trichinosis with mebendazole. Am J Trop Med Hyg1983;32:980-983.
61.
Lo Y-K. , Chao D., Yan S-H., et al: Spinal cord proliferative sparganosis in Taiwan: A case report. Neurosurgery1987 ; 21:235-238.
62.
Beaver PC, Rolon FA: Proliferating larval cestode in a man in Paraguay. Am J Trop Med Hyg1981;30:625-637.
63.
Spina-França A., Mattosinho-França LC: American trypanosomiasis (Chagas' disease), in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology: Infections of the Nervous System, part III, vol 35. New York, North-Holland, 1978, pp 85-114.
Pezzarossi HEZ , Ojeda-Román F., de la Vega SL, et al: Tripanosomiasis aguda. Reporte de un caso y revisión del tema. Rev Invest Clin1986;38:177-179.
66.
de Queiroz AC : Tumor-like lesion of the brain caused by Trypanosoma cruzi. Am J Trop Med Hyg1973;22:473-476.
67.
Leiguarda R. , Roncoroni A., Taratuto AL, et al: Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients . Neurology1990;40:850-851.
68.
Pitella JEH : Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquatria1984;42:105-115.
69.
Menezes ACO , Lopes ER, Chapadeiro E.: Estudo anatomopatológico sistematizado de encéfalos de chagásicos crônicos falecidos subitamente, letter. Rev InstMed TropSao Paulo1988;30:441-442.
70.
Rey RC, Monteverde DA, Sica REP: Cardiac sources of cerebral embolism, letter.Arch Neurol1991;48:359-360.
71.
Van Voorhis WC, Eisen H.: Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J Exp Med1989;169:641-652.
72.
Ronchi OJ, Ara CA: Meningoencephalitis chagasica en un lactante de cuarenta y cinco dias . Arch Argent Pediatr1953;39: 268-274.
73.
de Elizalde F., Scavuzzo FC, Basso NS: Enfermadad de Chagas-Mazza. Meningoencephalitis aguda en un lactante. Arch Argent Pediatr1952;38:225-231.
74.
Pittella JEH : Brain involvement in the chronic cardiac form of Chagas' disease. J Trop Med Hyg1985 ;88:313-317.
75.
Jörg ME , Freire RS, Orlando AS, et al: Disfunción cerebral minima como secuela de meningoencephalitis aguda por Trypanosoma cruzi. Estudio comparativo de la magnitud de la cerebropatia residual en 31 niños, 6 a 12 años tras la agresion inicial. Prensa Med Argent1972;59:1658-1669.
76.
del Castillo M., Mendoza G., Oviedo J., et al: AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med1990;88:693-694.
77.
A. Rocha A. , Meneses ACO, Silva AM, et al: Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med1994;50:261-268.
78.
Jost L., Turin M., Etchegoyen F., et al: Meningoencephalitis chagasica en paciente con tratamiento inmunosupresor por trasplante renal. Rev NeurolArgent1977;3:425-428.
79.
Seveler G., Taratut AH, de las Carrera MC, et al: Catatonia secondary to acute Chagas' encephalitis. J Neurol Neurosurg Psychiatry1987;50:1244.
80.
Wilson M., Schantz P.: Nonmorphologic diagnosis of parasitic infection, in Balows A, Hausler WJ Jr, Herrmann KL, et al (eds): Manual of Clinical Microbiology, 5th ed. Washington, DC, American Society for Microbiology, 1991, pp 717-726.
81.
Jörg ME : Encefalopatia por infeccion cronica con Trypanosoma cruzi. Ensayo de tratamiento con nifurtimox. Semana Med1973;142:941-957.
82.
McCabe RE, Meagher SG, Mullins BT: Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J Infect Dis1991;163:912-915.
83.
Fernandes BJ , Cooper JD, Cullen JB, et al: Systemic infection with Alaria americana (Trematoda). Can Med Assoc J1976; 115:1111-1114.
84.
Freeman RS, Stuart PF, Cullen JB, et al: Fatal human infection with mesocercariae of the trematode Alaria americana. Am J Trop Med Hyg1976;25:803-807.
85.
Kivits M.: Quatre cas d'encéphalite mortelle avec invasion du liquide céphalo-rachidien par Microfilaria loa. Ann Soc BelgeMed Trop1952;32:235-242.
86.
Negesse Y., Lanoie LO, Neafie RC, Connor DH: Loiasis: "Calabar" swellings and involvement of deep organs. Am J Trop Med Hyg1985;34:537-546.
87.
van Bogaert L., Dubois A., Janssens PG, et al: Encephalitis in Loa-loa filariasis . J Neurol Neurosurg Psychiatry1955;18: 103-119.
88.
Toussaint D. , Danis P.: Retinopathy in generalized Loa-loa filariasis. A clinicopathological study. Arch Ophthalmol1965;74:470-476,
89.
Fain A.: Les problèmes actuels de la loase. Bull World Health Organ1978;56:155-167.
90.
Carme B., Boulesteix J., Boutes H., Paruehnce MF: Five cases of encephalitis during treatment of loiasis with diethylcarbamazine . Am J Trop Med Hyg1991;44:684-690.
91.
Martin-Prevel Y., Cosnefroy J-Y., Tshipamba P., et al: Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg1993;48:186-192.
92.
Brumpt LC, Péquignot H., Lhermitte F., et al: Loase avec microfilarémie élevée, encéphalite thérapeutique, traitement par exsanguino-transfusion. Soc Med Hop Paris1966;117:1049-1058.
93.
Muylle L., Taelman H., Moldenhauer R., et al: Usefulness of apheresis to extract microfilarias in management of loiasis. BMJ1983;287:519-520.
94.
Chandenier J., Mollereau M., Datry A., et al: Intérêt de la cytaphérèse dans le traitement de la filariose à Loa-loa, letter. Presse Med1985;14:745.
95.
Nutman TB, Miller KD, Mulligan M., et al: Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study. N Engl J Med1988;319:752-756.
96.
Collomb H., Camerlynck P., Dumas M., et al: Syndrome d'hypertension intra-crânienne au cours d'une filariose a Wuchereria bancrofti (Cobbold, 1877). Bull Soc Pathol Exot1969;62:907-919.
97.
Dukes DC, Gelfand M., Gadd KG, et al: Cerebral filariasis caused by Acanthocheilonema perstans. Cent Afr J Med1968;14:21-27.
98.
Chambon M.: Présence de microfilaires dans le liquide céphalo-rachidien d'un trypanosomé avancé. Bull Soc Pathol Exot Filiales1933 ;26:613-614.
99.
Orihel TC: Cerebral filariasis in Rhodesia—a zoonotic infection ?Am J Trop Med Hyg1973;22:596-599.
100.
Ottesen EA, Vijayasekaran V., Kumaraswami V., et al: A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. N Engl J Med1990;322:1113-1117.
101.
A. Van den Enden E., Van Gompel A., Van der Stuft P., et al: Treatment failure of a single high dose of ivermectin for Mansonella perstans filariasis . Trans R Soc Trop Med Hyg1993;87:90.
102.
Sabin AB: Toxoplasmic encephalitis in children. JAMA1941; 116:801-807.
103.
Triki A., Couvreur J.: Les manifestations neuro-méningées de la toxoplasmose acquise. Tunis Med1971;49:323-329.
104.
Carey RM, Kimball AC, Armstrong D., Lieberman PH: Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med1973;54:30-38.
105.
Townsend JJ , Wolinsky JS, Baringer JR, Johnson PC: Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol1975;32:335-343.
106.
Ruskin J., Remington JS: Toxoplasmosis in the compromised host. Ann Intern Med1976;84:193-199.
107.
McCabe RE: Current diagnosis and management of toxoplasmosis in cancer patients. Oncology1990;4:81-94.
Luft BJ, Hafner R.: Toxoplasmic encephalitis. AIDS1990 ;4: 593-595.
110.
Herskovitz S., Siegel SE, Schneider AT, et al: Spinal cord toxoplasmosis in AIDS . Neurology1989;39:1552-1553.
111.
Shanks GD, Redfield RR, Fischer GW: Toxoplasma encephalitis in an infant with acquired immunodeficiency syndrome . Pediatr Infect Dis J1987;6:70-71.
112.
Cohen-Addad NE, Joshi VV, Sharer LR, et al: Congenital acquired immunodeficiency syndrome and congenital toxoplasmosis: Pathologic support for a chronology of events. J Perinatol1988 ;8:328-331.
113.
Medlock MD , Tilleli JT, Pearl GS: Congenital cardiac toxoplasmosis in a newborn with acquired immunodeficiency syndrome. Pediatr Infect Dis J1990;9:129-132.
114.
Mitchell CD , Erlich SS, Mastrucci MT, et al: Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1. Pediatr Infect Dis J1990;9:512-518.
115.
Burns DK: The neuropathology of pediatric acquired immunodeficiency syndrome . J Child Neurol1992;7:332-346.
116.
Luft BJ, Castro KG: An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: Implication for future therapeutic trials. Eur J Clin Microbiol Infect Dis1991; 10:178-181.
117.
Wahn V., Kramer HH, Voit T., et al: Horizontal transmission of HIV infection between two siblings . Lancet1986;2:694.
Derouin F. , Mazeron MC, Garin YIF: Comparative study of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii. J Clin Microbiol1987;25:1597-1600.
120.
Potasman I. , Resnick L., Luft BJ, Remington JS: Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med1988;108:49-51.
121.
Holliman RE , Johnson JD, Savva D.: Diagnosis of cerebral toxoplasmosis in association with AIDS using the polymerase chain reaction . Scand J Infect Dis1990;22:243-244.
122.
Mitchell CD: Toxoplasmosis in Pizzo PA, Wilfert CM (eds): Pediatric AIDS. The Challenge of HIV Infection in Infants, Children and Adolescents. Baltimore, Williams & Wilkins, 1991, pp 419-431.
123.
Post MJD , Kursunoglu SJ, Hensley GT, et al: Cranial CT in acquired immunodeficiency syndrome: Spectrum of diseases and optimal contrast enhancement technique . AJR Am J Roentgenol1985;145:929-940.
124.
Navia BA, Petito CK, Gold JWM, et al: Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients. Ann Neurol1986;19:224-238.
125.
Ciricillo SF, Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg1990;73:720-724.
126.
Kupfer MC, Zee C-S., Colletti PM, et al: MRI evaluation of AIDS-related encephalopathy: Toxoplasmosis vs lymphoma. Magn Reson Imaging1990;8:51-57.
127.
Gray F., Gherardi R., Wingate E., et al: Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. J Neurol1989;236:273-277.
128.
Wong SY, Remington J.: Toxoplasmosis in the setting of AIDS, in Broder S, Merigan TC Jr, Bolognesi D, (eds): Medical Management of AIDS. Baltimore, Williams & Wilkins, 1994, pp 223-258.
129.
Oster S., Hutchinson F., McCabe R.: Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine. Rev Infect Dis1990;12:618-620.
130.
Simon DI, Brosius FC III, Rothstein DM: Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Arch Intern Med1990;150:2379-2384.
131.
Katlama C. : Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Eur J Clin Microbiol Infect Dis1991 ;10:189-191.
132.
Danneman B. , McCutchan A., Israelski D., et al: Treatment of toxoplasmic encephalitis in patients with AIDS: A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med1992;116:33-43.
133.
Luft BJ, Hafner R., Korzun AH, et al: Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med1993;329:995-1000.
134.
Beaman MH, Luft BJ, Remington JS: Prophylaxis for toxoplasmosis in AIDS. Ann Intern Med1992; 117: 163-164.
135.
Remington JS, Vilde JL, Antunes F., et al: Clindamycin for toxoplasmosis encephalitis in AIDS. Lancet1991;338:1142-1143.
136.
Marinho SD : Estrongiloidose fatal com verifiçaçao anátomopatológica do parsita no cérebro. Apresentação de um caso. Hospital1963;64:615-623.
137.
Rogers WA Jr, Nelson B.: Strongyloidiasis and malignant lymphoma. "Opportunistic infection" by a nematode. JAMA1966;195:173-175.
138.
Yim Y. , Kikkawa Y., Tanowitz H., Wittner M.: Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy. J Trop Med Hyg1970; 73:245-249.
139.
Neefe LI, Pinilla O., Garagusi VF, Bauer H.: Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am J Med1973;55:832-838.
140.
Bradley SL , Dines DE, Brewer NS: Disseminated Strongyloides stercoralis in an immunosuppressed host. Mayo Clin Proc1978 ;53:332-335.
141.
Meltzer RS , Singer C., Armstrong D., et al: Antemortem diagnosis of central nervous system strongyloidiasis. Am J Med Sci1979 ;277:91-98.
142.
Wang T., Reyes CV, Kathuria S., Strinden C.: Diagnosis of Strongyloides stercoralis in sputum cytology. Acta Cytol1980; 24:40-43.
143.
Masdeu JC, Tantulavanich S., Gorelick PP, et al: Brain abscess caused by Strongyloides stercoralis. Arch Neurol1982;39:62-63.
144.
Dutcher JP , Marcus SL, Tanowitz HB, et al: Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitt's lymphoma . Cancer1990;66:2417-2420.
145.
Cruz T., Reboucas G., Rocha H.: Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med1966;275:1093-1096.
146.
Purtilo DT , Meyers WM, Connor DH: Fatal strongyloidiasis in immunosuppressed patients. Am J Med1974 ;56:488-493.
147.
Armignacco O., Capecchi A., De Mori P: Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome, letter. Am J Med1989;86:258.
148.
Neto VA, Pasternak J., Moreira AAB, et al: Strongyloides stercoralis hyperinfection in the acquired immunodeficiency syndrome, letter. Am J Med1989;87:602-603.
149.
Owor R., Wamukota WM: A fatal case of strongyloidiasis with Strongyloides larvae in the meninges . Trans R Soc Trop Med Hyg1976;70:497-499.
150.
Baermann G. : Eine einfache Methode zur Auffmdung von Ankylostomum (Nematoden) Larven in Erdproben. Mededeel Geneesk Lab Weltevreden, Feestbundel , Batavia, pp 41-47. Cited in Faust EC: Human Helminthology , 2nd ed. Philadelphia, Lea & Febiger, 1939, pp 601-602, 711.
151.
A. Garcia LS, Bruckner DA (eds): Diagnostic Medical Parasitology , 2nd ed. Washington, DC, American Society for Microbiology1994.
152.
Harris RA, Musher DM, Fainstein V., et al: Disseminated strongyloidiasis. Diagnosis made by sputum examination . JAMA1980;244:65-66.
153.
Panosian KJ , Marone P., Edberg SC: Elucidation of Strongyloides stercoralis by bacterial-colony displacement. J Clin Microbiol1986;24:86-88.
154.
Genta RM, Douce RW, Walzer PD: Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol1986;23: 1099-1103.
155.
Liu LX , Weller PF: Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am1993;7:655-682.
156.
Alvarez H. , Terashima A., Tello R., et al: Treatment of Strongyloides hyperinfection with ivermectin, abstract No. 224. Programs and abstracts of the 32nd Interscience Conference of Antimicrobial Agents and Chemotherapy, Anaheim , 1992, p 148.
157.
Margileth AM, Strano AJ, Chandra R., et al: Disseminated nosematosis in an immunologically compromised infant. Arch Pathol1973;95:145-150.
158.
Sprague V. : Nosema connori n sp, a microsporidian parasite of man. Trans Am Microsc Soc1974;93:400-402.
159.
Bergquist NR, Stintzing G., Smedman L., et al: Diagnosis of encephalitozoonosis in man by serological tests. BMJ1984; 288:902.
160.
Matsubayashi H., Koike T., Mikata I., et al: A case of Encephalitozoon-like body infection in man. Arch Pathol1959;67:181-187.
161.
Weiss LM, Cali A., Levee E., et al: Diagnosis of Encephalitozoon cuniculi infection by Western blot and the use of cross-reactive antigens for the possible detection of microsporidiosis in humans. Am J Trop Med Hyg1992;47:456-462.
162.
Hollister WS, Canning EU: An enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Encephalitozoon cuniculi and its use in determination of infections in man. Parasitology1987;94:209-219.
163.
Diesenhouse MC, Wilson LA, Corrent GF, et al: Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am J Ophthalmol1993 ; 115:293.
164.
Dieterich DT, Lew EA, Kotler DP, et al: Treatment with albendazole for intestinal disease due to Enterocytozoon bienusi in patients with AIDS. J Infect Dis1994;169:178-183.
